Stephan Gehring

University of Applied Sciences Mainz — Germany

Immunology and Microbiology · Life Sciences

25h-index2.1kcitations139works2.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immunotherapy and Immune Responses(20), RNA Interference and Gene Delivery(14), Hepatitis B Virus Studies(12), Mosquito-borne diseases and control(10), Hepatitis C virus research(9)

Publications139 total

Zika-Virus-Infektionen
2025
Yersiniose
2025
<i>Staphylococcus aureus</i> colonization and bloodstream infection in very preterm infants
Gut Microbes·2025· 1 citedOpen Access
CFTR modulator therapy drives microbiome restructuring through improved host physiology in cystic fibrosis: the IMMProveCF phase IV trial
Nature Communications·2025· 4 citedOpen Access
Insufficient immune protection in preterm infants due to delayed or incomplete hexavalent vaccination
Frontiers in Immunology·2025Open Access
Non-malarial etiology of acute febrile episodes in children attending five healthcare facilities in Mwanza, Tanzania years 2020–2021
Scientific Reports·2025Open Access
Incorporation of monophosphoryl lipid A and CpG-oligodeoxynucleotides into lipid nanoparticles activates toll-like receptor signaling pathways while maintaining antigen expression for mRNA-based vaccinations
International Journal of Biological Macromolecules·2025Open Access
3D-printed biopolymer matrices for the vehiculization and controlled release of octenidine in wound antibiotic therapy
Journal of Drug Delivery Science and Technology·2025Open Access
1500P SOLARIS: A phase-II open-label Study of pembrOlizumab and Lenvatinib in patients with Advanced stage hepatocellular carcinoma who are Refractory to atezolizumab and bevacizumab/ IO-baSed therapy (IKF t-037 trial)
Annals of Oncology·2025Open Access
Artemisinin and partner drug resistance markers in Plasmodium falciparum from Tanzanian paediatric malaria patients, 2016–2022
Malaria Journal·2025Open Access
mRNA-LNP vaccines against hepatitis B virus induce protective immune responses in preventive and chronic mouse challenge models
Molecular Therapy·2025· 3 citedOpen Access
Assessment of Prehospital Care for Pediatric Patients with Thermal Injuries: A Retrospective Study
Journal of Clinical Medicine·2025Open Access
Phytoactive-Loaded Lipid Nanocarriers for Simvastatin Delivery: A Drug Repositioning Strategy Against Lung Cancer
Pharmaceutics·2025· 1 citedOpen Access
mRNA-LNP vaccines against Hepatitis B virus induce protective immune responses in preventive and chronic mouse challenge models
2025Open Access
mRNA-LNP vaccine strategies: Effects of adjuvants on non-parenchymal liver cells and tolerance
Molecular Therapy — Methods & Clinical Development·2025· 4 citedOpen Access
Vektorübertragene Erkrankungen im Kindesalter
Monatsschrift Kinderheilkunde·2024
Advancing Probiotic Intervention Studies in Preterm Infants—Reply
JAMA Pediatrics·2024
Ernährungsrisiken in Säuglings- und Kleinkindalter
Monatsschrift Kinderheilkunde·2024
Encapsulation of Dexamethasone into mRNA–Lipid Nanoparticles Is a Promising Approach for the Development of Liver-Targeted Anti-Inflammatory Therapies
International Journal of Molecular Sciences·2024· 11 citedOpen Access
Malaria and dengue fever in febrile children entering healthcare facilities in Mwanza, Tanzania
PLoS ONE·2024· 4 citedOpen Access
page 1 of 7Next →

Frequent Co-authors

Claudius U. Meyer(11), Michael Fichter(10), Katharina Landfester(10), Fred Zepp(8), Stephen H. Gregory(8), Leah Pretsch(7), Jack R. Wands(6), Britta Gröndahl(6), Volker Mailänder(6), Maximiliano L. Cacicedo(6), Philip Wintermeyer(5), Sebastian Wirsching(5), Grit Baier(5), Peer Bork(4), Markus Knuf(4), Dorothee Viemann(4), Michael Zemlin(4), Philipp Henneke(4), Anette Pietrzak-Nguyen(4), Katja Hilbert(4)